Department of Neuroscience, University of Rome Tor Vergata Via Montpellier 1 Rome 00133 and IRCCS S. Lucia, Via Ardeatina 300 00100 Rome, Italy.
Glycobiology. 2010 May;20(5):500-6. doi: 10.1093/glycob/cwp202. Epub 2010 Jan 5.
D-(-)-Lentiginosine [(-)-4], the nonnatural enantiomer of the iminosugar indolizidine alkaloid L-(+)-lentiginosine, acts as apoptosis inducer on tumor cells of different origin, in contrast to its natural enantiomer. Although D-(-)-4 exhibited a proapoptotic activity towards tumor cells at level lower than the chemotherapeutic agent, SN38, it was less proapoptotic towards normal cells and less cytotoxic. Apoptosis induced by D-(-)-4 was caspase-dependent, as shown by the increased expression and activity of caspase-3 and -8 in treated cells, and by inhibition following treatment with the pan caspase inhibitor, ZVAD-FMK. This study highlighted how a natural iminosugar alkaloid and its synthetic enantiomer, which were simply known for their inhibition against a fungal glucoamylase, could behave in a complete different way when tested towards cell growth and death of cells of different origin.
D-(-)-Lentiginosine [(-)-4],作为天然的异映体 indolizidine 生物碱 L-(+)-lentiginosine 的非天然对映异构体,与天然对映异构体相反,它可以作为不同来源肿瘤细胞的凋亡诱导剂。尽管 D-(-)-4 对肿瘤细胞的促凋亡活性低于化疗药物 SN38,但它对正常细胞的促凋亡作用和细胞毒性较低。D-(-)-4 诱导的细胞凋亡依赖于半胱天冬酶,这可以通过用广谱半胱天冬酶抑制剂 ZVAD-FMK 处理后细胞中半胱天冬酶-3 和 -8 的表达和活性增加来证明。这项研究强调了一种天然的异映体生物碱及其合成的对映异构体,它们仅因其对真菌葡糖淀粉酶的抑制作用而被人们所知,当对不同来源的细胞生长和死亡进行测试时,它们的行为可能完全不同。